Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer

Por Magné, N, Fischel, J L, Dubreuil, A, Formento, P, Marcié, S, Lagrange, J-L, Milano, G
Publicado em 2002

Genetic alterations and field defect in head and neck squamous cell carcinoma

Por Strzelczyk J K, Krakowczyk Ł, Kwaśniewski M, Płachetka A, Gołąbek K, Chwiałkowska K, Maciejewski A, Wiczkowski A
Publicado em 2012-12-01

Incidence of Radiation Caries in Patients Undergoing Radiation Therapy in the Head and Neck Region

Por A KONJHODZIC-PRCIC, J KEROS, M AJANOVIC, N SMAJKIC, L HASIC-BRANKOVIC
Publicado no Pesquisa Brasileira em Odontopediatria e Clínica Integrada (2010)

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer

Por Ferris, R. L., Geiger, J. L., Trivedi, S., Schmitt, N. C., Heron, D. E., Johnson, J. T., Kim, S., Duvvuri, U., Clump, D. A., Bauman, J. E., Ohr, J. P., Gooding, W. E., Argiris, A.
Publicado no Ann Oncol (2016)

Are job strain and sleep disturbances prognostic factors for neck/shoulder/arm pain? A cohort study of a general population of working age in Sweden

Por Rasmussen-Barr, E, Grooten, W J A, Hallqvist, J, Holm, L W, Skillgate, E
Publicado em 2014

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a...

Por Temam, S, Spicer, J, Farzaneh, F, Soria, J C, Oppenheim, D, McGurk, M, Hollebecque, A, Sarini, J, Hussain, K, Soehrman Brossard, S, Manenti, L, Evers, S, Delmar, P, Di Scala, L, Mancao, C, Feuerhake, F, Andries, L, Ott, M G, Passioukov, A, Delord, J P
Publicado no Ann Oncol (2017)

FDG–PET. A possible prognostic factor in head and neck cancer

Por Halfpenny, W, Hain, S F, Biassoni, L, Maisey, M N, Sherman, J A, McGurk, M
Publicado em 2002

Quantitative lymph node burden as a ‘very-high-risk’ factor identifying head and neck cancer patients benefiting from postoperative chemoradiation

Por Zumsteg, Z S, Luu, M, Kim, S, Tighiouart, M, Mita, A, Scher, K S, Lu, D J, Shiao, S L, Mallen-St. Clair, J, Ho, A S
Publicado no Ann Oncol (2019)

Quantitative lymph node burden as a ‘very-high-risk’ factor identifying head and neck cancer patients benefiting from postoperative chemoradiation

Por Zumsteg, Z S, Luu, M, Kim, S, Tighiouart, M, Mita, A, Scher, K S, Lu, D J, Shiao, S L, Mallen-St. Clair, J, Ho, A S
Publicado no Ann Oncol (2019)

Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891

Por Lefebvre, J.-L., Andry, G., Chevalier, D., Luboinski, B., Collette, L., Traissac, L., de Raucourt, D., Langendijk, J. A.
Publicado em 2012

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients...

Por Dunn, L A, Fury, M G, Xiao, H, Baxi, S S, Sherman, E J, Korte, S, Pfister, C, Haque, S, Katabi, N, Ho, A L, Pfister, D G
Publicado no Ann Oncol (2018)

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients...

Por Dunn, L. A., Fury, M. G., Xiao, H., Baxi, S. S., Sherman, E. J., Korte, S., Pfister, C., Haque, S., Katabi, N., Ho, A. L., Pfister, D. G.
Publicado no Ann Oncol (2017)

Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer

Por Argiris, A., Karamouzis, M. V., Smith, R., Kotsakis, A., Gibson, M. K., Lai, S. Y., Kim, S., Branstetter, B. F., Shuai, Y., Romkes, M., Wang, L., Grandis, J. R., Ferris, R. L., Johnson, J. T., Heron, D. E.
Publicado em 2011

Renal clear cell carcinoma metastasis to submandibular gland: case report and review of the literature

Por Higuera, F, Boccalatte, L A, Labanca, M J, Jaén del Valle, A, Larrañaga, J J, Figari, M F
Publicado no J Surg Case Rep (2018)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Por Pivot, X, Raymond, E, Laguerre, B, Degardin, M, Cals, L, Armand, J P, Lefebvre, J L, Gedouin, D, Ripoche, V, Kayitalire, L, Niyikiza, C, Johnson, R, Latz, J, Schneider, M
Publicado em 2001

Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis

Por Soria, J C, Morat, L, Commo, F, Dabit, D, Perie, S, Sabatier, L, Fouret, P
Publicado em 2001

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer(†)

Por Argiris, A., Bauman, J. E., Ohr, J., Gooding, W. E., Heron, D. E., Duvvuri, U., Kubicek, G. J., Posluszny, D. M., Vassilakopoulou, M., Kim, S., Grandis, J. R., Johnson, J. T., Gibson, M. K., Clump, D. A., Flaherty, J. T., Chiosea, S. I., Branstetter, B., Ferris, R. L.
Publicado no Ann Oncol (2016)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Por Cohen, E. E. W., Licitra, L. F., Burtness, B., Fayette, J., Gauler, T., Clement, P. M., Grau, J. J., del Campo, J. M., Mailliez, A., Haddad, R. I., Vermorken, J. B., Tahara, M., Guigay, J., Geoffrois, L., Merlano, M. C., Dupuis, N., Krämer, N., Cong, X. J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P. H.
Publicado no Ann Oncol (2017)

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck

Por Schnoell J, Jank BJ, Kadletz-Wanke L, Stoiber S, Gurnhofer E, Schlederer M, Heiduschka G, Kenner L
Publicado em 2022-05-01

Frontoethmoidal encephalocele in a cat

Por Woerde, Dennis J, Hoffmann, Karon L, Brown, Narelle L
Publicado no JFMS Open Rep (2018)